CEL-SCI (CVM) Scheduled to Post Quarterly Earnings on Tuesday
Shares of CEL-SCI (NYSEAMERICAN CVM) opened at $1.82 on Tuesday. CEL-SCI has a 52 week low of $1.46 and a 52 week high of $4.50.
CVM has been the subject of a number of research analyst reports. Dawson James reissued a “neutral” rating on shares of CEL-SCI in a research report on Monday, October 16th. ValuEngine raised shares of CEL-SCI from a “strong sell” rating to a “sell” rating in a research report on Monday, August 14th.
ILLEGAL ACTIVITY WARNING: “CEL-SCI (CVM) Scheduled to Post Quarterly Earnings on Tuesday” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.americanbankingnews.com/2017/12/05/cel-sci-cvm-scheduled-to-post-quarterly-earnings-on-tuesday.html.
CEL-SCI Company Profile
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.
Receive News & Ratings for CEL-SCI Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI Co. and related companies with MarketBeat.com's FREE daily email newsletter.